Cargando…
Aggravated Atherosclerosis and Vascular Inflammation With Reduced Kidney Function Depend on Interleukin-17 Receptor A and Are Normalized by Inhibition of Interleukin-17A
Effective therapy of atherosclerotic complications in patients with chronic kidney disease (CKD) is an unmet clinical need. Cardiovascular events are the most common cause of death. At a glomerular filtration rate ≤60 ml/min, these events are increased also after correction for common risk factors....
Autores principales: | Nordlohne, Johannes, Helmke, Alexandra, Ge, Shuwang, Rong, Song, Chen, Rongjun, Waisman, Ari, Haller, Hermann, von Vietinghoff, Sibylle |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6058956/ https://www.ncbi.nlm.nih.gov/pubmed/30062194 http://dx.doi.org/10.1016/j.jacbts.2017.08.005 |
Ejemplares similares
-
Interleukin 17 Receptor A Modulates Monocyte Subsets and Macrophage Generation In Vivo
por: Ge, Shuwang, et al.
Publicado: (2014) -
Surface-bound bovine serum albumin carrier protein as present in recombinant cytokine preparations amplifies T helper 17 cell polarization
por: Dong, Lei, et al.
Publicado: (2016) -
Inhibition of Interleukin-17A, But Not Interleukin-17F, Signaling Lowers Blood Pressure, and Reduces End-Organ Inflammation in Angiotensin II–Induced Hypertension
por: Saleh, Mohamed A., et al.
Publicado: (2016) -
Analysis of interleukin-17 and interleukin-18 levels in animal models of atherosclerosis
por: Tang, Xiuming
Publicado: (2019) -
Expression of interleukin-17RC protein in normal human tissues
por: Ge, Dongxia, et al.
Publicado: (2008)